EQUITY	3 Months Ended
Sep. 30, 2021
EQUITY
NOTE 6 - EQUITY	NOTE 6 – EQUITY Preferred Stock The Company is authorized to issue 90,000,000 shares of preferred stock at a par value of $0.0001. No shares were issued and outstanding as of September 30, 2021 and June 30,2021, respectively. Common Stock The Company is authorized to issue 100,000,000 shares of common stock at a par value of $0.0001. As of September 30, 2021, and June 30, 2021, 7,753,598 shares of common stock were issued and outstanding. As of September 30, 2021, there were no warrants or options outstanding.

EQUITY

3 Months Ended

Sep. 30, 2021

NOTE 6 – EQUITY

Preferred Stock

The Company is authorized to issue 90,000,000 shares of preferred stock at a par value of $0.0001.

No shares were issued and outstanding as of September 30, 2021 and June 30,2021, respectively.

Common Stock

The Company is authorized to issue 100,000,000 shares of common stock at a par value of $0.0001.

As of September 30, 2021, and June 30, 2021, 7,753,598 shares of common stock were issued and outstanding.

As of September 30, 2021, there were no warrants or options outstanding.

Bionovate Technologies Corp. 10-Q